Ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease: Results from the phase 2 REACH1 trial Meeting Abstract


Authors: Jagasia, M.; Ali, H.; Schroeder, M. A.; Shah, N. N.; Chen, Y. B.; Dawkins, F.; Arbushites, M.; Tian, C.; Perales, M. A.
Abstract Title: Ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease: Results from the phase 2 REACH1 trial
Meeting Title: 2019 TCT Meetings of ASBMT and CIBMTR
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 25
Issue: 3 Suppl.
Meeting Dates: 2019 Feb 20-24
Meeting Location: Houston, TX
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2019-03-01
Start Page: S52
Language: English
ACCESSION: WOS:000540655500067
PROVIDER: wos
DOI: 10.1016/j.bbmt.2018.12.130
Notes: Meeting Abstract: 66 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Miguel-Angel Perales
    914 Perales